Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia

Our primary aim was to identify potential risk factors and clinical outcome of azanucleoside induced pulmonary complications in patients with myelodysplastic syndrome (MDS) and Acute Myelogenous Leukemia (AML). We present an 89-year-old female with MDS derived AML who developed fatigability, hypoxem...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina, Manuel, Yellapragada, Sarvari, Mims, Martha, Rahman, Effie, Rivero, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698523/
https://www.ncbi.nlm.nih.gov/pubmed/26798526
http://dx.doi.org/10.1155/2015/357461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698523/
https://www.ncbi.nlm.nih.gov/pubmed/26798526
http://dx.doi.org/10.1155/2015/357461

Ejemplares similares